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ABSTRACT The survival of commensal bacteria in the human gut partially de-
pends on their ability to metabolize host-derived molecules. The use of the gly-
cosidic moiety of N-glycoproteins by bacteria has been reported, but the role of
N-glycopeptides or glycoamino acids as the substrates for bacterial growth has not been
evaluated. We have identified in Lactobacillus casei strain BL23 a gene cluster (alf-2) in-
volved in the catabolism of the glycoamino acid fucosyl--1,6-N-GlcNAc-Asn (6=FN-Asn),
a constituent of the core-fucosylated structures of mammalian N-glycoproteins. The
cluster consists of the genes alfHC, encoding a major facilitator superfamily (MFS)
permease and the -L-fucosidase AlfC, and the divergently oriented asdA (aspartate
4-decarboxylase), alfR2 (transcriptional regulator), pepV (peptidase), asnA2 (glycosyl-
asparaginase), and sugK (sugar kinase) genes. Knockout mutants showed that alfH,
alfC, asdA, asnA2, and sugK are necessary for efficient 6=FN-Asn utilization. The alf-2
genes are induced by 6=FN-Asn, but not by its glycan moiety, via the AlfR2 regula-
tor. The constitutive expression of alf-2 genes in an alfR2 strain allowed the metabo-
lism of a variety of 6=-fucosyl-glycans. However, GlcNAc-Asn did not support growth
in this mutant background, indicating that the presence of a 6=-fucose moiety is cru-
cial for substrate transport via AlfH. Within bacteria, 6=FN-Asn is defucosylated by
AlfC, generating GlcNAc-Asn. This glycoamino acid is processed by the glycosylas-
paraginase AsnA2. GlcNAc-Asn hydrolysis generates aspartate and GlcNAc, which is
used as a fermentable source by L. casei. These data establish the existence in a
commensal bacterial species of an exclusive metabolic pathway likely to scavenge
human milk and mucosal fucosylated N-glycopeptides in the gastrointestinal tract.
IMPORTANCE The gastrointestinal tract accommodates more than 1014 microorgan-
isms that have an enormous impact on human health. The mechanisms enabling
commensal bacteria and administered probiotics to colonize the gut remain largely
unknown. The ability to utilize host-derived carbon and energy resources available
at the mucosal surfaces may provide these bacteria with a competitive advantage in
the gut. Here, we have identified in the commensal species Lactobacillus casei a
novel metabolic pathway for the utilization of the glycoamino acid fucosyl--1,6-N-
GlcNAc-Asn, which is present in the core-fucosylated N-glycoproteins from mammali-
ans. These results give insight into the molecular interactions between the host and
commensal/probiotic bacteria and may help to devise new strategies to restore gut
microbiota homeostasis in diseases associated with dysbiotic microbiota.
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Many investigations have recently highlighted the importance of the gut microbi-ota in the onset and progression of a number of human diseases, including
gastrointestinal disorders (1, 2), inflammatory diseases (3), respiratory tract infections
(4), and allergies (5). The functional impact of commensal gut microorganisms depends
on their ability to survive in the gastrointestinal tract, adhere to epithelial mucus, and
obtain energy from nondigestible dietary substrates and host mucosal secretions (6).
More than half of all proteins in nature have been estimated to be glycosylated through
O-glycosidic or N-glycosidic bonds (7). O-Glycans are linked to a serine or threonine
residue via an N-acetylgalactosamine, which is elongated by additional sugars (8).
N-Glycosylation is a common modification of extracellular membrane proteins present
at the gastrointestinal epithelium, the secreted proteins of human breast milk, and
many dietary proteins (7, 9–11). N-Linked glycans are attached via the core N,N=-
diacetylchitobiose disaccharide (ChbNAc) (GlcNAc-1,4-GlcNAc) to an asparagine resi-
due of proteins containing the Asn-Xxx-Ser/Thr (with Xxx being any amino acid except
Pro) motif (12). In N-glycans from mammals, the inner GlcNAc moiety bound to Asn is
often fucosylated through an 1,6 linkage, named core fucose. Protein N-glycosylation
plays a crucial role in a variety of cellular processes, such as cell adhesion (13), immune
pathway signaling (14), and bacterial recognition (15). Some intestinal microorganisms
have the ability to process the carbohydrate moieties of N-glycosylated proteins (16) so
that the type, abundance, and location of these glycans contribute to shaping the
composition and distribution of the gut microbiota (17). Some bacterial pathogens
possess endo--N-acetylglucosaminidase enzymes that cleave the -1,4 linkage of the
core ChbNAc present in all N-glycoproteins, releasing the N-glycan moiety (18). The
activities of these enzymes have been associated with the modification of the biological
function of host defense glycoproteins, such as immunoglobulins and lactoferrin
(19–21), and with the use of the glycans as nutrients (21), for which they are considered
virulence factors (22). In commensal bacteria, the ability to remove N-glycans from
glycoproteins has been described in a few Bifidobacterium species (23, 24). Recently, the
importance of core-fucosylated N-glycans from human milk in promoting the intestinal
growth of Bifidobacterium and Lactobacillus species has been demonstrated in lactating
infants from mothers carrying different alleles of the fucosyltransferase Fut8, respon-
sible for core fucosylation (25). This provides the first in vivo evidence of the importance
of this core structure in feeding intestinal commensals. However, there is little infor-
mation about the fate of the fucosyl--1,6-GlcNAc bound to proteins through the Asn
residue (6=FN-Asn). This glycoamino acid possibly results from the combined action of
endo--N-acetylglucosaminidase enzymes and proteases on N-glycosylated proteins
(18, 23, 24). The amide bond between the amino acid and the GlcNAc residue is
hydrolyzed by two different enzymes, peptide-N(4)-(-N-acetylglucosaminyl)-L-
asparaginases (glycopeptide N-glycosidase) (PNGase) (EC 3.5.1.52) and N(4)-(-N-
acetylglucosaminyl)-L-asparaginases (glycosylasparaginase) (EC 3.5.1.26). Both types of
enzymes are produced as precursors that undergo intramolecular autoproteolysis to
produce the mature active proteins (26, 27), but PNGases require the presence of more
than 2 amino acid residues in the substrate (28), whereas glycosylasparaginases act
only in asparagine-oligosaccharides containing 1 amino acid (29). Currently, bacterial
PNGases have been characterized only from the human pathogens Elizabethkingia
meningoseptica and Elizabethkingia miricola (30, 31) and from the soil bacterium
Terriglobus roseus (32). In E. meningoseptica, a glycosylasparaginase has also been
characterized (33, 34).
Lactobacillus casei is a lactic acid bacterium able to survive in the gastrointestinal
tract (35, 36), which has been isolated from a wide variety of habitats, including feces
of breastfed infants (37, 38), and several strains are commonly used as probiotics in
functional foods (39, 40). Oligosaccharides present in human milk, such as lacto-N-biose
and N-acetyllactosamine, and derived from mucins, such as galacto-N-biose, can sup-
port the growth of L. casei (41, 42). This species is also able to catabolize lacto-N-triose
(43) and fucosyl--1,3-N-acetylglucosamine (44), which are abundant carbohydrates
that form part of larger glycan structures from human gut mucosas and human milk.
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Unlike glycans, catabolic pathways for N-glycopeptides in bacteria have not been
described. In this work, we have identified in L. casei BL23 a gene cluster, named alf-2,
involved in the metabolism of the glycoamino acid fucosyl--1,6-N-GlcNAc-Asn (6=FN-
Asn). The results reported here have enabled us to propose a catabolic pathway for
6=FN-Asn and -1,6-fucosylated N-glycans in bacteria.
RESULTS
Identification of the L. casei alf-2 gene cluster involved in the metabolism of
the glycoamino acid 6=FN-Asn. We had previously shown that the disaccharide
fucosyl--1,6-N-acetylglucosamine (6=FN) is hydrolyzed in vitro by the L. casei BL23
-L-fucosidase AlfC (glycosyl hydrolase family 29 [GH29]) (45). However, this bacterium
is unable to grow in the presence of 6=FN as a carbon source (44). Analysis of the DNA
region (GenBank accession no. FM177140) (46) around alfC revealed a gene cluster
named here alf-2 (Fig. 1A). This cluster consists of the genes alfHC (LCABL_RS14345 and
LCABL_RS14350), which encode a major facilitator superfamily (MFS) permease and
AlfC, respectively, and, divergently oriented, the genes asdA (LCABL_RS14340), alfR2
FIG 1 (A) Structural organization of the Lactobacillus casei BL23 alf-2 operon. (B) Schematic representation of the transport
and catabolic pathways for fucosyl--1,6-N-acetylglucosamine-asparagine, fucosylated glycans (fucosyl--1,6-N-
acetylglucosamine, fucosyl--1,6-glucose, fucosyl--1,6-galactose, and fucosyl--1,6-N,N=-diacetylchitobiose), and fucosy-
lated N-glycopeptides in Lactobacillus casei. AlfC, -L-fucosidase AlfC; AsnA2, N(4)-(-N-acetylglucosaminyl)-L-asparaginase;
AsdA, aspartate 4-decarboxylase; PepV, peptidase V; SugK, sugar kinase.
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(LCABL_RS14335), pepV (LCABL_RS14330), asnA2 (LCABL_RS14325), and sugK (LCA-
BL_RS14320). These genes encode proteins annotated as aspartate 4-decarboxylase
(asdA), a GntR family transcriptional regulator (alfR2), peptidase M20 (pepV), N(4)-(-N-
acetylglucosaminyl)-L-asparaginase (asnA2), and a ROK (repressor, open reading frame
[ORF], kinase) family protein (sugK). Two putative rho-independent terminators were
identified downstream of alfC (ΔG, 13.5 kcal/mol) and sugK (ΔG, 17.0 kcal/mol). The
high specificity of the -L-fucosidase AlfC from L. casei BL23 for 1,6 linkages such as
those present at fucosyl-oligosaccharides (45, 47), together with the sequence analysis
of the alf-2 cluster, particularly the presence of a gene coding for a hypothetical
N(4)-(-N-acetylglucosaminyl)-L-asparaginase, suggested that the alf-2 operon could be
involved in the metabolism of the core 6=FN-Asn (Fig. 1). To test this hypothesis, this
glycoamino acid was synthesized by transfucosylation with the -L-fucosidase AlfC. We
had previously utilized AlfC in transglycosylation reactions with p-nitrophenyl--L-
fucopyranoside (pNP-fuc) as the donor and GlcNAc as the acceptor to produce 6=FN
(47). Here, the ability of AlfC to use GlcNAc-Asn as the acceptor was tested, and
6=FN-Asn was synthesized and purified. The purified 6=FN-Asn was characterized by
nuclear magnetic resonance (NMR) spectroscopy (Fig. 2A) (see Fig. S1 and Table S1 in
the supplemental material). ChbNAc, galactose, and glucose were also used in trans-
fucosylation reactions with AlfC, and the glycans fucosyl--1,6-N,N=-diacetylchitobiose
FIG 2 1H NMR spectra of compounds in D2O acquired at 27°C at 600 MHz with an inverse cryoprobe. (A) Fucosyl--1,6-N-acetylglucosamine-asparagine
(6=FN-Asn); (B) fucosyl--1,6-N,N=-diacetylchitobiose (N2F N-glycan); (C) fucosyl--1,6-galactose (6=FucGal); (D) fucosyl--1,6-glucose (6=FucGlc). Signals labeled
with Fu correspond to copurified L-fucose.
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(N2F N-glycan), which forms part of the core fucosylation; fucosyl--1,6-galactose
(6=FucGal); and fucosyl--1,6-glucose (6=FucGlc) were also synthesized (Fig. 2B to D and
Table S1).
To determine whether L. casei BL23 is able to use 6=FN-Asn, GlcNAc-Asn, N2F
N-glycan, 6=FucGal, or 6=FucGlc as a carbon source, its growth profiles in MRS basal
medium supplemented with each compound were analyzed. L. casei grew only in the
presence of the glycoamino acid 6=FN-Asn (Fig. 3A). The analysis of the carbohydrate
content of the growth medium showed that BL23 did not degrade any of the assayed
glycans (Fig. 3C). However, the AlfR2-deficient strain (BL405) could degrade all the
synthesized 6=-fucosyl oligosaccharides, as evidenced by the quantitative accumulation
of L-fucose in the supernatant and the disappearance of the peaks corresponding to the
fucosylated substrates (Fig. 3C). The presence of L-fucose in the culture supernatants
FIG 3 Growth profiles of Lactobacillus casei on N-glycan derivatives. (A and B) L. casei wild-type strain BL23 (A) and strain BL405, an alfR2
deletion mutant (B), grown on MRS basal medium without a carbon source or with fucosyl--1,6-N-acetylglucosamine-asparagine
(6=FN-Asn), fucosyl--1,6-N-acetylglucosamine (6=FN), N-acetylglucosamine-asparagine (GlcNAc-Asn), fucosyl--1,6-glucose (6=FucGlc),
fucosyl--1,6-galactose (6=FucGal), or fucosyl--1,6-N,N=-diacetylchitobiose (N2F N-glycan). (C) HPLC chromatograms (Dionex system) of
the standard compounds L-fucose (0.25 mM) (chromatogram 1), 6=FN (0.2 mM) (chromatogram 2), N2F N-glycan (0.2 mM) (chromatogram
3), 6=FucGlc (0.2 mM) (chromatogram 4), and 6=FucGal (0.2 mM) (chromatogram 5) and culture supernatants (diluted 20 times) from L. casei
BL23 (WT) (chromatograms 6, 8, 10, 12, and 14) and BL405 (alfR2) (chromatograms 7, 9, 11, 13, and 15) grown in 6=FN (chromatograms
6 and 7), 6=FucGlc (chromatograms 8 and 9), 6=FucGal (chromatograms 10 and 11), or N2F N-glycan (chromatograms 12 and 13) or without
sugar (chromatograms 14 and 15). The numbers by the L-fucose peaks indicate the concentration (millimolar). nC, nanoCoulomb.
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was due to the fact that L. casei does not metabolize L-fucose and excretes it into the
culture medium (44). Nevertheless, growth with these carbon sources was very poor
compared to that with 6=FN-Asn (Fig. 3B). Interestingly, like the wild type (WT), the alfR2
mutant strain did not use GlcNAc-Asn (Fig. 3B). These results suggested that AlfR2
represses the expression of alf-2 genes and that the presence of 6=FN-Asn is required
to relieve repression. Furthermore, the existence of an L-fucose moiety with an 1,6
linkage configuration is possibly necessary for the uptake of the tested fucosyl oligo-
saccharides, including 6=FN-Asn.
Transcription of the alf-2 gene cluster is induced by 6=FN-Asn and repressed by
AlfR2. To find out whether the transcription of the alf-2 genes is regulated by the
glycoamino acid 6=FN-Asn or its glycan moiety, reverse transcription-quantitative PCR
(RT-qPCR) experiments were performed with RNA isolated from L. casei BL23 grown
with 6=FN-Asn, 6=FN, GlcNAc, or glucose (Fig. 4). The results showed that the alf-2
operon is induced by the glycoamino acid 6=FN-Asn and not by the presence of 6=FN
or GlcNAc, indicating that the glycoamino acid and not the glycan moiety is responsible
for the induction of these genes and explaining the lack of growth of the wild type on
N2F N-glycan, 6=FucGal, and 6=FucGlc. In order to obtain direct evidence for the
regulation of AlfR2 on these genes, RNA was isolated from the alfR2 deletion strain
BL405 cultured under the same conditions as those for the wild type (Fig. 4). Regardless
of the substrate tested, the expression levels of alf-2 genes were higher than those in
the wild type growing on glucose, indicating that AlfR2 indeed acts as a transcriptional
repressor.
The AlfC -L-fucosidase and the AlfH permease are necessary for the metab-
olism of 6=FN-Asn and 6=-fucosyl-oligosaccharides. To assess the role of alfC and alfH
in the catabolism of 6=FN-Asn in L. casei, the growth patterns of mutant strains
disrupted in alfC (BL415) and alfH (BL372) were analyzed in MRS basal medium
supplemented with the fucosylated glycoamino acid (Fig. 5A and B). The profiles
showed that both mutants failed to grow on 6=FN-Asn. To further confirm that the
glycoamino acid was not fermented, culture supernatant analyses were performed, and
they showed that 6=FN-Asn remained in BL415 and BL372 supernatants, without the
appearance of L-fucose (Fig. 5E). The amount of L-fucose (1.12 mM) present in both
supernatants corresponded to the amount of L-fucose copurified with the synthesized
6=FN-Asn (Fig. 2 and Fig. 5E). These results demonstrated that the -L-fucosidase AlfC
FIG 4 Expression of alf-2 genes in Lactobacillus casei. L. casei BL23 (WT) and L. casei BL405 (alfR2 deletion
mutant) were grown in MRS basal medium containing fucosyl--1,6-N-acetylglucosamine-asparagine (6=FN-
Asn), fucosyl--1,6-N-acetylglucosamine (6=FN), or N-acetylglucosamine (GlcNAc). Gene expression in L.
casei BL405 in the presence of glucose is also shown. Expression was monitored by RT-qPCR, and L. casei
BL23 (WT) cells grown in MRS basal medium with glucose were used as a reference. Data presented are
mean values based on at least three replicates. Bars indicate standard errors.
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FIG 5 Growth curves of Lactobacillus casei mutant strains. (A and B) BL415 (alfC) (A) and BL372 (alfH) (B) on MRS basal medium without a carbon
source or with fucosyl--1,6-N-acetylglucosamine-asparagine (6=FN-Asn) or N-acetylglucosamine (GlcNAc). (C and D) BL406 (alfR2 alfC) (C) and BL407
(Continued on next page)
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is involved in the metabolism of 6=FN-Asn and that the permease AlfH participates in
its transport. To determine the role of AlfC and AlfH in the utilization of the rest of the
fucosyl-glycans synthesized here (6=FN, 6=FucGlc, 6=FucGal, and N2F N-glycan), two
double mutant strains, BL406 (alfR2 alfC) and BL407 (alfR2 alfH), were constructed. Both
mutants showed growth patterns with 6=-fucosyl-glycans similar to that of the
negative-control culture without an added carbohydrate (Fig. 5C and D). In addition,
the results showed a final culture optical density (OD) of strain BL406 or BL407 that was
significantly lower than that of strain BL405 (alfR2) on these sugars (Table S2). These
results indicated that the -L-fucosidase AlfC and the permease AlfH are also involved
in their metabolism and transport, respectively. 6=FN-Asn was also tested as a carbon
source in the culture medium with these double mutants, confirming the requirement
of a functional -L-fucosidase and permease for its metabolism (Fig. 5C and D).
6=FN-Asn catabolism requires AsdA, AsnA2, and SugK but not PepV. An asdA
mutant strain (BL416) showed impaired growth in MRS basal medium supplemented
with 6=FN-Asn (Fig. 6A). Curiously, the glycoamino acid was completely depleted from
the culture supernatant (Fig. 5E); however, the mutant strain reached a lower optical
density than the wild-type strain, suggesting that asdA is involved in 6=FN-Asn metab-
olism. A BLAST search using the deduced amino acid sequence of AsdA against the
genomic sequence of L. casei BL23 did not reveal the presence of other AsdA paral-
ogues. AsdA belongs to the Asp aminotransferase family (cd00609), which also includes
a number of enzymes with decarboxylase or racemase activities. The BL23 genome
encoded 11 hypothetical carboxylases (https://www.ncbi.nlm.nih.gov/genome/proteins/
652?genome_assembly_id300266); whether AsdA is a decarboxylase and whether any
of these enzymes would complement its activity need to be investigated. A pepV
mutant strain (BL417) showed a growth pattern similar to that of the wild-type strain
(Fig. 6B), indicating that the hypothetical peptidase encoded by this gene is not
essential for the metabolism of 6=FN-Asn. The two genes asnA2 and sugK, present
downstream of pepV, were, however, necessary for the utilization of 6=FN-Asn by L.
casei. An asnA2 (BL418) mutant strain constructed here and a sugK (BL392) mutant
characterized previously (41) failed to grow on 6=FN-Asn (Fig. 6C and D). These results
indicate that both the putative glycosylasparaginase AsnA2 and the putative sugar
kinase SugK are required for the catabolism of 6=FN-Asn.
AsnA2 has glycosylasparaginase activity. The capacity to catabolize 6=FN-Asn by
L. casei indicated that AsnA2 probably encodes a glycosylasparaginase that would
cleave the linkage between GlcNAc and Asn. To confirm this hypothesis, AsnA2 was
overexpressed as a His-tagged protein and purified (Fig. S2). The molecular weight of
His-tagged AsnA2 was estimated to be 55.6 kDa using size exclusion chromatography,
which does not coincide with the theoretical molecular mass (36.071 kDa), suggesting
that the enzyme probably forms dimers. Interestingly, when the purified AsnA2 fraction
was subjected to SDS-PAGE analysis, three bands were observed: a very faint band at
about 38.0 kDa and two other bands with estimated molecular weights of 18.2 and
17.8 kDa. Mass spectrometry (MS) analysis showed that all three protein bands were
derived from the glycosylasparaginase AsnA2 (data not shown). The 38-kDa band
corresponds to the full-length protein, whereas the 18.2- and 17.8-kDa fragments
correspond to the N-terminal and C-terminal domains, respectively. Therefore, AsnA2 is
probably a zymogen that is processed during purification. A mechanism of intramo-
FIG 5 Legend (Continued)
(alfR2 alfH) (D) on MRS basal medium without a carbon source or with 6=FN-Asn, fucosyl--1,6-N-acetylglucosamine (6=FN), fucosyl--1,6-glucose
(6=FucGlc), fucosyl--1,6-galactose (6=FucGal), fucosyl--1,6-N,N=-diacetylchitobiose (N2F N-glycan), or GlcNAc. The four mutant strains were grown
in MRS basal medium with GlcNAc as a positive control. (E) HPLC chromatograms (Dionex system) of the supernatants (diluted 10 times) from
Lactobacillus casei strain cultures. Shown are chromatograms of the standards L-fucose (0.4 mM) (chromatogram 1), GlcNAc (0.1 mM) (chromatogram
2), N-acetylglucosamine-asparagine (GlcNAc-Asn) (0.1 mM) (chromatogram 3), and 6=FN-Asn (0.1 mM) (chromatogram 4). Also shown are chro-
matograms of the culture supernatants from L. casei BL23 (WT) cultured without added sugar (chromatogram 5) or from L. casei strains cultured
on 6=FN-Asn, including BL23 (WT) (chromatogram 6), BL418 (asnA2) (chromatogram 7), BL417 (pepV) (chromatogram 8), BL416 (asdA) (chromato-
gram 9), BL415 (alfC) (chromatogram 10), BL372 (alfH) (chromatogram 11), BL392 (sugK) (chromatogram 12), and BL405 (alfR2) (chromatogram 13).
The numbers by the L-fucose peaks indicate the concentration (millimolar). nC, nanoCoulomb.
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lecular autoproteolysis has been previously described for glycosylasparaginases and
PNGases (26, 27). The self-processing of the precursor protein occurs at a Thr residue,
and the two fragments form a noncovalent heterodimeric complex (26). A BLAST search
with the amino acid sequence of L. casei AsnA2 evidenced 28% sequence identity to the
glycosylasparaginase of E. meningoseptica (26). The sequence alignment between both
proteins revealed that all residues involved in autoproteolytic processing, including the
catalytic Thr residue (Thr-154 in AsnA2), are conserved. We analyzed the activity of the
purified AsnA2 by measuring the release of GlcNAc from GlcNAc-Asn, which confirmed
that AsnA2 is an N(4)-(-N-acetylglucosaminyl)-L-asparaginase (Fig. S2). This exhibited a
specific activity of 20.91 mol mg protein1 min1 for GlcNAc-Asn. The activity of
AsnA2 on the fucosylated glycoamino acid was also tested (Fig. S2). In contrast to the
human glycosylasparaginase, which does not act on 6=FN-Asn (48), AsnA2 was able to
degrade 6=FN-Asn, releasing 6=FN with a specific activity of 0.26 mol mg pro-
tein1 min1. These results indicated that AsnA2 preferentially acts on GlcNAc-Asn over
the fucosylated substrate 6=FN-Asn.
AsdA displays aspartate 4-decarboxylase activity, and SugK displays kinase
activity. As described below, the Asp resulting from the activity of AsnA2 on GlcNAc-
Asn might be the substrate for the AsdA enzyme. To test this hypothesis, AsdA was
overexpressed with a His tag and purified. Recombinant AsdA showed decarboxylation
activity on L-Asp, with a specific activity of 10.97  2.27 nmol mg protein1 min1. This
weak activity on L-Asp might indicate that this amino acid is not the preferred substrate
for AsdA. Regarding SugK, the proposed pathways for 6=FN-Asn and 6=-fucosyl-glycans
(Fig. 1B) involved the release of the monosaccharides GlcNAc, Glc, and Gal, which
should be phosphorylated by specific kinases before entering glycolysis. In order to
FIG 6 Growth curves of Lactobacillus casei mutant strains. Shown are growth curves for BL416 (asdA) (A), BL417 (pepV) (B),
BL418 (asnA2) (C), and BL392 (sugK) (D) on MRS basal medium without a carbon source or with fucosyl--1,6-N-
acetylglucosamine-asparagine (6=FN-Asn) or N-acetylglucosamine (GlcNAc). In all graphs, the growth pattern of wild-type
(WT) strain BL23 is presented for a better comparison.
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prove whether SugK showed kinase activity on these sugars, it was overexpressed as a
His-tagged protein and purified. SugK displayed kinase activity on GlcNAc (1.44 mol
mg protein1 min1) but could not phosphorylate Glc and Gal. Activity on
N-acetylgalactosamine (GalNAc) was also assayed, as this N-acetylhexosamine is also
very abundant on mucosa-associated glycans, and no activity on this sugar was
detected.
Proposed pathway for 6=FN-Asn catabolism in L. casei. The genetic and bio-
chemical evidence reported here allows the proposal of a catabolic pathway for
6=FN-Asn in L. casei (Fig. 1B). The glycoamino acid is internalized by the permease AlfH,
which has broad specificity over a range of 6=-fucosylated substrates, and is subse-
quently defucosylated by the -L-fucosidase AlfC, generating L-fucose and GlcNAc-Asn.
The released L-fucose is excreted from the cells by an as-yet-undetermined mechanism,
while GlcNAc-Asn is split by AsnA2 into Asp and 1-amino-GlcNAc, which is unstable,
and it is nonenzymatically converted to GlcNAc and ammonium (49, 50). The require-
ment of AlfC for 6=FN-Asn utilization and the lower affinity of AsnA2 for 6=FN-Asn than
for GlcNAc-Asn support that the catabolism of 6=FN-Asn occurs through the consecu-
tive actions of AlfC and AsnA2. GlcNAc produced by the action of AsnA2 on GlcNAc-Asn
would then be the substrate for the sugar kinase SugK (Fig. 1). The other resulting
product of AsnA2 activity, Asp, might be the substrate of AsdA, although the weak
aspartate 4-decarboxylase activity could indicate that AsdA may play an as-yet-
undetermined role in this pathway. Regarding the function of pepV, which encodes a
putative peptidase, no signal peptide was evidenced for it, suggesting that it is a
cytoplasmic protein. The permease AlfH might also transport more complex substrates,
like N-glycosylated peptides derived from the proteolysis of host- and food-derived
proteins. Furthermore, the fact that AlfC is able to release L-fucose from core fucosy-
lation of the Fc fragment from immunoglobulins (51) shows that this enzyme has the
capacity to hydrolyze -1,6 linkages in polypeptidic substrates and could act on
core-fucosylated N-glycopeptides. In this case, after the release of L-fucose by AlfC,
amino acids would be removed by PepV to liberate GlcNAc-Asn (Fig. 1B).
DISCUSSION
N-Glycosylated proteins are present at human mucosal surfaces and in breast milk
(9, 10, 52), and therefore, they can be accessible to the gut microbiota. Most studies
about energy sources for gut-beneficial microbes have been focused on carbohydrates
present in the diet or added as prebiotics (53), whereas knowledge about the catab-
olism of host-derived carbon and nitrogen sources is scarce (16). We have demon-
strated that L. casei is able to metabolize the glycoamino acid 6=FN-Asn, which is the
core structure of the N-glycan sites of 1,6-fucosylated glycoproteins. The relevance of
the metabolism of this core structure for intestinal microbial ecology was recently
established in vivo in humans and in mouse models with reduced 1,6-fucosylation of
core structures (25). In this work, we filled the existing gap relative to the metabolic
pathways involved in the utilization of core-fucosylated N-glycopeptides by bacteria.
The backbone of the L. casei 6=FN-Asn pathway consists of the MFS transporter AlfH; the
-L-fucosidase AlfC, which removes the 1,6-fucosyl residue; and the glycosylaspara-
ginase AsnA2, which processes the resulting GlcNAc-Asn to 1-amino-GlcNAc and Asp
(Fig. 1B). The generated 1-amino-GlcNAc is not metabolizable, but this compound is
unstable at acidic pH, and it degrades into GlcNAc and ammonium (49). As lactobacilli
do not maintain a constant internal pH, but it decreases as the external pH drops (54),
intracellular conditions may allow the spontaneous degradation of 1-amino-GlcNAc.The
resulting GlcNAc would then be the substrate for the sugar kinase SugK, allowing its
channeling through glycolysis.
The genetic organization of the L. casei alf-2 gene cluster is well conserved in gene
content and gene order across the L. casei-Lactobacillus paracasei-Lactobacillus rham-
nosus phylogenetically related group of lactobacilli, excepting the absence of asdA in
L. rhamnosus (Fig. 7). Homologues of alfC are present in only a few Lactobacillus species,
and the closest homologues are harbored by some bifidobacteria isolated from Hyme-
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FIG 7 Structural organization of the alf-2 gene clusters from Lactobacillus rhamnosus GG, Lactobacillus heilongjiangensis DSM 28069, Lactobacillus nantensis DSM
16982, Lactobacillus melliventris Hma8, Bifidobacterium asteroides Bin2, Bifidobacterium actinocoloniiforme DSM 22766, Lactobacillus manihotivorans DSM 13343,
Lactobacillus gasseri ATCC 33323, Lactobacillus johnsonii ATCC 33200, Lactobacillus curvatus MRS6, and Lactobacillus sakei LS25. Stem-loop structures in L. casei
DNA represent putative rho-independent terminators. Surrounding genes near the alf-2 genes are also shown. The organization of the Lactobacillus casei BL23
alf-2 operon is also shown for a better comparison. PTS, phosphotransferase system.
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noptera (55–57) (see Fig. S3A in the supplemental material). Interestingly, many lacto-
bacilli carrying alfC have also been isolated from insects (58, 59). Phylogenetic analyses
of these genes show that they constitute a well-supported cluster together with the
alfC gene of Vagococcus humatus. More distant homologues are mostly present in gut
anaerobic bacteria (Fig. S3A). Homologues of L. casei alfH are mostly found in the same
set of species, although this gene is also present in other bifidobacteria and in
Lactobacillus kisonensis (Fig. S3B). The genetic association of these genes in these
species and their close phylogenetic relationships suggest that they share an origin and
an evolutionary history. Homologues of AsnA2 (Fig. S4), AsdA (Fig. S5), and PepV
(Fig. S6) are present in numerous lactobacilli. Indeed, Lactobacillus gasseri ATCC 33323,
which carries a gene cluster with asnA2, pepV, and alfR2 (Fig. 7), was recently shown to
grow with 6=FN and N2F N-glycan (25). However, in the same work, L. casei ATCC 334
was reported to use L-fucose, which is contradictory to the fact that no fuc genes are
present in its genome (60). In addition, L. casei ATCC 334 was also shown to metabolize
6=FN and N2F N-glycan (25), which, according to our results with L. casei BL23, can be
possible only if the repressor alfR2 is inactivated.
In bifidobacteria, AsnA2 homologues are present only in Bifidobacterium actinocolo-
niiforme, Bifidobacterium asteroides, and Bifidobacterium xylocopae (Fig. S4), and as for
their AlfC and AlfH counterparts, they are most closely related to Lactobacillus se-
quences. The limited presence in bifidobacteria and the phylogenetic clustering of the
three bifidobacterial genes within Lactobacillus sequences suggest that they were
transferred from Lactobacillus to Bifidobacterium. Genes encoding PepV homologues
are absent in bifidobacteria, whereas asdA genes have been detected only in Bifido-
bacterium magnum and Bifidobacterium gallicum. The AsdA bifidobacterial sequences
constitute a well-supported cluster with sequences from the Bacteroidetes and are not
closely related to their Lactobacillus counterparts (Fig. S5), indicating that they had a
different evolutionary origin. Interestingly, the closest relatives of L. casei pepV are
genetically linked to asnA2 homologues (Fig. 7). This observation suggests a functional
link between PepV and AsnA2.
Glycosylasparaginases (EC 3.5.1.26) are essential for the removal of the sugar moiety
from the Asn in the GlcNAc-Asn structures derived from N-glycoproteins in humans (29,
61). These enzymes cleave the -aspartylglucosamine linkage, and they require both a
free -amino and -carboxy group on the Asn substrate (29). In lactobacilli, an asnA2
homologue had been previously identified in Lactobacillus sakei as a gene induced
during meat (sausage) fermentation, and a knockout mutant resulted in reduced
growth on meat, but its activity was not ascertained (62). In contrast to the Elizabeth-
kingia glycosylasparaginase, AsnA2 from L. casei characterized here lacks a signal
peptide, strongly suggesting that it is an intracellular enzyme. As described above for
glycosylasparaginases, AsnA2 suffers a self-processing proteolytic process to render an
active enzyme (Fig. S2). The mature AsnA2 enzyme did not show activity on glycosy-
lated proteins (Fig. S2D), but it showed in vitro activity on 6=-fucosylated and nonfu-
cosylated GlcNAc-Asn. Curiously, the presence of the linked L-fucose blocks the hydro-
lysis of 6=FN-Asn by the human glycosylasparaginase (29). However, for the related
PNGases, it has been demonstrated that the size of the carbohydrate moiety in the
substrate has little effect on their activity (63). Therefore, AsnA2 would exhibit inter-
mediate characteristics between both types of enzymes: -1,6-linked L-fucose does not
block hydrolysis, and the enzyme does not require a glycosylated peptide as the
substrate.
We previously characterized the -L-fucosidase AlfC from L. casei (45) and demon-
strated that it displays high regiospecific transglycosylation activity that produces 6=FN
disaccharide (47). This enzyme constitutes the only characterized bacterial -L-
fucosidase acting on -1,6 linkages in core fucosylation structures (core fucosidase),
and it was recently employed as a tool for IgG glycoengineering to obtain defucosy-
lated immunoglobulins with enhanced antibody cell-mediated toxicity (51). Core fuco-
sylation of N-glycopeptides and N-glycoproteins has also been attained using L. casei
AlfC mutant enzymes (64). In addition to GlcNAc, we show here that AlfC is able to use
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GlcNAc-Asn, ChbNAc, galactose, and glucose as acceptor substrates in transfucosylation
reactions. All the synthesized compounds (6=FN-Asn, N2F N-glycan, 6=FucGal, and
6=FucGlc) have exclusively -1,6-fucosidic bonds, confirming the high linkage specificity
of AlfC. However, the recognition of different acceptors indicates a relaxed substrate
specificity.
Wild-type L. casei did not metabolize the 6=-fucosyl-glycans 6=FN, N2F N-glycan,
6=FucGal, and 6=FucGlc, probably due, as shown for 6=FN, to their inability to induce the
alf-2 operon. This was confirmed by inactivating alfR2, which resulted in the constitu-
tive expression of alf-2 genes and the subsequent catabolism of these oligosaccharides.
Although alf-2 operon induction required the complete glycoamino acid 6=FN-Asn, the
coexistence of this and other 6=-fucosyl-glycans in environments such as the gastroin-
testinal tract might allow their simultaneous utilization. Complex networks of cross-
feeding between bacteria exist in the gastrointestinal niche, and these substrates are
probably released into the gut by the concerted action of different microbial enzymes
on glycoproteins and other glycocomplexes (21, 23, 24, 62). The results presented here
describe the first catabolic route for the utilization of 6=-fucosyl-related compounds in
bacteria. They support previous works that assign to N-glycoproteins a role in nour-
ishing beneficial bacteria in the gut. In addition, they show that commensals and
pathogens share related mechanisms to take advantage of host molecules.
MATERIALS AND METHODS
Transfucosylation reactions. The AlfC -L-fucosidase was expressed and purified as previously
described (45). The transfucosylation activity of 6His-AlfC was also analyzed as previously indicated
(47), with some modifications. The reaction mixtures (1 ml) contained 100 mM Tris-HCl buffer (pH 7.0);
50 mM p-nitrophenyl--L-fucopyranoside (pNP-fuc) as the donor; and GlcNAc-Asn (100 mM), N,N=-
diacetylchitobiose (150 mM), galactose (150 mM), or glucose (150 mM) as the acceptor. The mixtures
were heated at 98°C to solubilize pNP-fuc and then cooled to 42°C. Reactions were started by adding 800
U/ml AlfC, and after 20 min (reaction with GlcNAc-Asn as an acceptor), 15 min (reaction with galactose
as an acceptor), and 10 min (reactions with N,N=-diacetylchitobiose or glucose as an acceptor), they were
heated at 98°C for 3 min to stop the reaction. The maximum yields obtained for 6=FN-Asn, N2F N-glycan,
6=FucGal, and 6=FucGlc were 3.6 g/liter, 1.8 g/liter, 1.3 g/liter, and 3.3 g/liter, respectively. One-
dimensional (1D) 1H and two-dimensional (2D) 1H and 13C heteronuclear single quantum coherence
(HSQC) and 2D heteronuclear multiple-bond correlation (HMBC) NMR analyses demonstrated the exclu-
sive formation of an 1,6-glycosidic linkage between the sugar monomers.
Analytical and semipreparative HPLC analyses. Transfucosylation reaction products were purified
by high-performance liquid chromatography (HPLC) using a preparative Rezex RCM-monosaccharide
column (Phenomenex) as previously described (65). Appropriate fractions were pooled, concentrated,
and analyzed by using an analytical Rezex RSO-oligosaccharide column (Phenomenex) in the case of
6=FN-Asn synthesis and an analytical Rezex RCM-monosaccharide column (Phenomenex) in the case of
N2F N-glycan, 6=FucGal, and 6=FucGlc synthesis. The synthesized compounds 6=FN-Asn, N2F N-glycan,
6=FucGal, and 6=FucGlc were subjected to complete hydrolysis with the -L-fucosidase AlfC, and the
released L-fucose was measured in order to determine their concentrations.
To determine the glycoamino acids and carbohydrates present in the supernatants from the
Lactobacillus strain cultures, the bacterial cells were removed by centrifugation, and the cultures were
analyzed with an ICS3000 chromatographic system (Dionex) using a CarboPac PA100 column with pulsed
amperometric detection. A gradient of 10 mM to 100 mM NaOH was used for 16 min at a flow rate of
1 ml/min.
Nuclear magnetic resonance spectroscopy. Samples for nuclear magnetic resonance (NMR) spec-
troscopy were prepared as previously described (66). NMR spectra were also recorded as previously
indicated (66), with some modifications. 1H-13C HSQC data were acquired with 360 transients over a
spectral width of 10 ppm (for 1H) and 160 to 220 ppm (for 13C) and 128 points in the indirect dimension.
Total correlation spectroscopy (TOCSY) data were acquired with 64 transients over a spectral width of
10 ppm in both dimensions and 128 points in the indirect dimension. NMR spectra were processed using
the program MesReNoeva 8.1 (Mestrelab Research SL).
Bacterial strains and culture conditions. Lactobacillus strains (Table 1) were grown at 37°C under
static conditions in MRS medium (Difco). Escherichia coli was used as a cloning host, and it was routinely
grown in Luria-Bertani medium (Oxoid) with shaking at 37°C. The corresponding solid media were
prepared by adding 1.8% agar. L. casei growth assays with different carbon sources were carried out in
MRS basal medium as previously described (41). 6=FN-Asn, 6=FucGal, 6=FucGlc, 6=FN, GlcNAc-Asn, GlcNAc,
or glucose was added to MRS basal medium at a concentration of 4 mM, and N2F N-glycan was added
at 2 mM. Bacterial growth was determined in microtiter plates with a POLARstar Omega plate reader
(BMG Labtech). At least three independent biological replicates for each growth curve were obtained,
and a representative growth curve is shown. For each biological replicate comparing the wild type and
a mutant strain, the same batch of MRS basal medium was used. The concentrations of glycoamino acids
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and carbohydrates in the culture supernatants at the end of fermentation were determined by HPLC as
described above.
E. coli strains were transformed by electroporation with a Gene Pulser apparatus (Bio-Rad), as
recommended by the manufacturer. E. coli DH10B transformants were selected with ampicillin (100 g/
ml), and E. coli BE50 transformants were selected with ampicillin (100 g/ml) and kanamycin (50 g/ml).
L. casei strains were transformed as described previously (67). L. casei transformants were selected with
erythromycin (5 g/ml).
Construction of L. casei mutants in alf-2 genes. L. casei BL23 chromosomal DNA was isolated as
previously described (67) and used as the template for PCRs, which were performed with the Expand
high-fidelity PCR system (Roche). The alfR2 gene was amplified by PCR using the primer pair AspDecaFor/
XhoPeptVRev2 (see Table S3 in the supplemental material). The resulting 1,289-bp fragment was ligated
into pRV300 (68) digested previously with EcoRV/KpnI and treated with the Klenow fragment of DNA
polymerase I. The obtained plasmid was digested with SalI, ligated, and transformed. A clone with a
466-bp deletion in alfR2 (pRValfR2) was selected. DNA fragments containing parts of asdA, pepV, and
asnA2 were obtained by PCR using the oligonucleotides pairs AsdFor/AsdRev, PepVFor/PepVRev, and
AsnFor/AsnRev, respectively (Table S3), and cloned into pRV300 digested with EcoRV. The resulting
plasmids, pRVasdA, pRVpepV, and pRVasnA, were cleaved at the unique HindIII, NcoI, and BclI restriction
sites present in the asdA, pepV, and asnA2 coding regions, respectively, to introduce frameshifts into their
corresponding coding sequences (Table 1). The three digested plasmids were then treated with Klenow
fragment, ligated, and transformed into E. coli DH10B. The resulting plasmids were transformed into L.
casei BL23, and frameshifts were introduced into the corresponding genes by a double-recombination
strategy (41) (Table 1). To construct an alfC mutant, an internal DNA fragment of alfC was obtained by
PCR using the oligonucleotides AlfCFor and AlfCRev. The PCR product was cloned into pRV300 digested
with EcoRV. The resulting plasmid, pRValfC, was used to transform L. casei BL23, and single-crossover
integrants were selected by resistance to erythromycin and confirmed by PCR analysis and DNA
sequencing. One mutant was selected and named BL415. The same procedure was used to inactivate alfC
in the mutant strain BL405 (alfR2), obtaining the alfR2 alfC double mutant (strain BL406). To construct the
alfR2 alfH double mutant (strain BL407), the plasmid pRValfH was generated (Table 1). A DNA fragment
TABLE 1 Strains and plasmids used in this studya





BL23 Wild type CECT 5275
BL372 BL23 alfH::pRV300 Ermr 44
BL392 BL23 sugK::pRV300 Ermr 41
BL405 BL23 alfR2 (466-bp internal deletion at alfR2) This work
BL406 BL23 alfR2 alfC (466-bp internal deletion at alfR2 and alfC::pRV300 Ermr) This work
BL407 BL23 alfR2 alfH (466-bp internal deletion at alfR2 and frameshift in alfH at the BclI site) This work
BL415 BL23 alfC::pRV300 Ermr This work
BL416 BL23 asdA (frameshift at the HindIII site) This work
BL417 BL23 pepV (frameshift at the NcoI site) This work
BL418 BL23 asnA2 (frameshift at the BclI site) This work
Escherichia coli
DH10B F endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 80lacZΔM15 araD139 Δ(ara leu)7697
mcrA Δ(mrr-hsdRMS-mcrBC) 
Invitrogen
GM119 F supE44 lacY1 galK2 galT22 metB1 dcm-6 dam-3 tsx-78  ATCC 53339
BE50 BL21(DE3) containing pREPGroES/GroEL 80
PE149 DH10B containing pQEalfC 45
PE173 BE50 containing pQEasnA2 This work
PE174 BL21(DE3)/pLys containing pETasdA This work
PE176 BE50 containing pQEsugK This work
Plasmids
pRV300 Suicide vector carrying Ermr from pAM1 68
pRValfR2 pRV300 with a fragment carrying a 466-bp deletion at the alfR2 coding region This work
pRVasdA pRV300 with a frameshift at the HindIII site in the asdA fragment This work
pRVpepV pRV300 with a frameshift at the NcoI site in the pepV fragment This work
pRVasnA pRV300 with a frameshift at the BclI site in the ansA fragment This work
pRValfC pRV300 with a 669-bp alfC fragment This work
pRValfH pRV300 with a frameshift at the BclI site in the alfH fragment This work
pQE80 E. coli expression vector; Ampr Qiagen
pET-28a() E. coli expression vector; Kanr Novagen
pQEasnA2 pQE80 containing the asnA2 coding region This work
pETasdA pET-28a() containing the asdA coding region This work
pQEsugK pQE80 containing the sugK coding region This work
aCECT, Colección Española de Cultivos Tipo; Ermr, erythromycin resistant; Ampr, ampicillin resistant; Kanr, kanamycin resistant.
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containing part of alfH was obtained with the oligonucleotide pair FucPerFor/FucPerRev and cloned into
pRV300 digested with EcoRV. The resulting plasmid, pRValfH, was cleaved at the unique BclI restriction
site present in the alfH coding region, treated with Klenow fragment, ligated, and transformed. A
construct in which a frameshift was introduced at the BclI site in alfH (pRValfH) was selected. pRValfH was
transformed into the mutant strain BL405 (alfR2). A clone having a second recombination event was
selected to obtain the alfR2 alfH double mutant (strain BL407).
Sequence analysis. DNA sequencing was carried out by the Central Service of Research Support of
the University of Valencia (Spain). M13 universal and reverse primers or custom primers hybridizing
within the appropriate DNA fragments were used for sequencing. Sequence analyses were carried out
with DNAMAN 4.03 for Windows (Lynnon BioSoft), and sequence similarities were analyzed with the
BLAST program (69). Genomic context analysis was performed at the Microbial Genome Database for
Comparative Analysis (MBGD) (http://mbgd.genome.ad.jp/) (70).
Reverse transcription-quantitative PCR analysis. Total RNA was isolated from L. casei strains BL23
(WT) and BL405 (alfR2) grown in MRS basal medium supplemented with 4 mM different glycans
(6=FN-Asn, 6=FN, GlcNAc, or glucose), as previously described (41). The isolated RNA was digested with
DNase I and retrotranscribed using the Maxima first-strand cDNA synthesis kit (Fermentas) (41). Reverse
transcription-quantitative PCR (RT-qPCR) was performed for each cDNA sample in triplicate using the
LightCycler 480 system (Roche), LC fast-start DNA master SYBR green I (Roche), and the primers pairs
q29280for/q29280rev (sugK), q29290for/q29290rev (asnA2), q29300for/q29300rev (pepV), q29310for/
q29310rev (alfR2), q29320for/q29320rev (asdA), q29330for/q29330rev (alfH), and q29340for/q29340rev
(alfC) (Table S3). The reaction mixtures and cycling conditions were previously described (41). The pyrG,
lepA, and ileS genes were chosen as reference genes (71). Relative expression values were calculated
using the software tool REST (relative expression software tool) (72). Linearity and amplification efficiency
were determined for each primer pair.
Expression and purification of AsnA2, AsdA, and SugK. The coding regions of asnA2, asdA, and
sugK were amplified by PCR using the primer pairs AsnHindIIFor/AsnBamHIRev, AsdAHCt-F/AsdAHCt-R,
and SugKBamH1For/SugKRev, respectively (Table S3). AsnA2 was cloned into the HindIII-BamHI sites and
SugK was cloned into the BamHI-SmaI sites of the pQE80 vector and transformed into E. coli BE50
coexpressing the chaperones groES and groEL. pETasdA was constructed using the Gibson assembly kit
(NEB) with the asdA PCR fragment and pET28a() digested with NcoI and XhoI. pETasdA was trans-
formed into E. coli BL21(DE3)/pLys. For purification, cells were grown to an OD at 600 nm (OD600) of 0.8,
1 mM isopropyl--D-thiogalactopyranoside was added, and incubation was continued at 25°C for 10 h.
Bacterial cell extracts were loaded onto a HisTrap column (GE Healthcare), and His-tagged protein was
purified according to the supplier’s recommendations. The native molecular weight of the AsnA2 protein
was estimated by size exclusion chromatography (HiPrep 16/60 Sephacryl S-300 HR column).
Mass spectrometry analysis. Protein bands from AsnA2 purification were excised from the gel,
trypsinized, and analyzed with a 5800 matrix-assisted laser desorption ionization–tandem time of flight
(MALDI-TOF/TOF) system (AB Sciex) at the proteomics service of the University of Valencia. MS and
tandem MS (MS/MS) data were analyzed with the Mascot server.
AsnA2 enzyme activity. The activity of the purified AsnA2 enzyme was assayed at 37°C with
GlcNAc-Asn and 6=FN-Asn as the substrates. The released GlcNAc and 6=FN, respectively, were quantified
by analyzing the reaction mixtures by ionic chromatography (Dionex) as described above. Reactions
using mixtures (20 l) containing 5 mM the substrate in 100 mM Tris-HCl buffer (pH 7.0) were initiated
by adding 0.2 g of the enzyme. Protein deglycosylation assays were performed with reaction mixtures
(15 l) containing 3.75 g of ovalbumin or lactoferrin in 100 mM Tris-HCl buffer (pH 7.0). The reactions
were initiated with 0.2 g of the enzyme, and the mixtures were incubated at 37°C overnight.
AsdA enzyme activity. AsdA decarboxylase activity on L-Asp was measured as previously described,
with some modifications (73). The resulting L-Ala was detected by using a coupled enzyme assay.
Reactions using mixtures (100 l) containing 100 mM K-acetate buffer (pH 5.5), 0.2 mM pyridoxal
5-phosphate, 1 mM -ketoglutarate, 0.4 mM NAD, 0.32 U of L-alanine dehydrogenase (Sigma), and 10
g of AsdA were initiated by the addition of 40 mM L-Asp. Reaction mixtures were incubated for 60 min
at 37°C, and the production of NADH was monitored at 340 nm.
SugK enzyme activity. SugK phosphorylation activity on different sugars was determined by using
a coupled enzyme assay as previously described (74). Reactions using mixtures (100 l) containing
100 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM ATP, 1 mM phosphoenolpyruvate, 0.2 mM NADH, 10 U of
pyruvate kinase, 7 U of lactate dehydrogenase, and various substrates (GlcNAc, Glc, Gal, or GalNAc) at a
final concentration of 1 mM were initiated by the addition of 0.75 g of SugK. Reaction mixtures were
incubated for 15 min at 37°C, and NADH formation was monitored at 340 nm.
Phylogenetic analysis. Sequences of alfC, alfH, asnA2, asdA, and pepV homologues were retrieved
from the microbial genome repository at the NCBI by BLAST (75) using their corresponding L. casei BL23
protein sequences as query sequences. For asnA2, only sequences from the Lactobacillaceae and
Bifidobacteriaceae were included. Domain analysis was performed using the tools implemented at the
NCBI BLAST site (https://blast.ncbi.nlm.nih.gov/Blast.cgi). The resulting data sets were aligned with
M-Coffee (76) at the T-Coffee server (http://tcoffee.crg.cat), with default settings. Positions of uncertain
homology and gaps were removed using GBLOCKS (77) at the Gblocks server (http://molevol.cmima
.csic.es/castresana/Gblocks_server.html), allowing smaller final blocks and less strict flanking positions.
Redundant sequences were removed by using the EMBOSS suite Skipredundant tool (78) with a
percent sequence identity redundancy threshold of 98%. The best-fit models of amino acid substi-
tution and maximum likelihood trees were obtained using PhyML version 3.0 (79) at the PhyML
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server (http://www.atgc-montpellier.fr/phyml). Bootstrap support values were obtained from 1,000
pseudorandom replicates.
Statistical analysis. Student’s t test was performed using Statgraphics Plus version 2.1 (Statistical
Graphics Corp., USA), and it was used to detect statistically significant differences between the final OD
values reached by L. casei BL405 (alfR2) cultures and the mutant strains BL406 (alfR2 alfC) and BL407
(alfR2 alfH). Statistical significance was accepted at a P value of 0.05.
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